Opportunity Information: Apply for RFA AG 18 030

The National Institutes of Health (NIH) funding opportunity titled "Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required)" (Funding Opportunity Number RFA-AG-18-030; CFDA 93.866) is a discretionary health research grant designed to move promising dementia care and caregiver support approaches closer to real-world use. The central aim is not simply to test an intervention under ideal conditions, but to build the practical foundation needed for pragmatic trials and broader implementation in everyday community and clinical settings for people living with Alzheimer's disease and related dementias (ADRD) and for the family members and other caregivers who support them.

This FOA specifically supports early-stage behavioral intervention development clinical trials aligned with Stage I, II, and III of the NIH Stage Model. In plain terms, that means research teams are expected to work on developing, refining, and strengthening interventions before large-scale effectiveness trials. Projects can focus on adapting or modifying existing dementia care or caregiver interventions so they fit real-world constraints such as staffing, time, setting, cultural context, and available resources. The opportunity also emphasizes understanding what makes an intervention work by examining the underlying principles or mechanisms, rather than treating the program as a "black box."

A major theme is implementation readiness. Applicants are encouraged to develop and test methods that help ensure fidelity in the real world, meaning the intervention can be delivered consistently and correctly outside of tightly controlled research environments. Alongside fidelity, the FOA calls for development of training procedures for the people who will actually deliver the intervention in the community, such as care managers, social workers, nurses, community health workers, aging services staff, or other front-line personnel depending on the setting. The intent is to produce interventions that are not only effective in theory, but deliverable, teachable, and sustainable in the places where people with ADRD and their caregivers already receive support.

The award uses the NIH R01 mechanism and explicitly requires a clinical trial, signaling that funded projects must include prospective assignment to an intervention and evaluate health- or behavior-related outcomes consistent with NIH's clinical trial definition. The listed award ceiling is $350,000, and the original closing date for the opportunity was April 10, 2018, with the FOA created on February 5, 2018. The sponsoring agency is NIH.

Eligibility is broad and includes many types of organizations capable of conducting and partnering on community-engaged dementia intervention research. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicants and partnership-relevant institutions such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This wide eligibility reflects the FOA's real-world focus, where effective dementia care and caregiver support often depends on collaborations across healthcare systems, social services, community organizations, and culturally specific institutions.

Overall, the opportunity is aimed at accelerating the pathway from promising dementia care and caregiver support ideas to interventions that can realistically be delivered at scale. By funding early-stage clinical trials centered on adaptation, mechanism-focused refinement, fidelity strategies, and practical training approaches, NIH is seeking projects that reduce the gap between research and routine practice for ADRD care and caregiving support.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2018-02-05.
  • Applicants must submit their applications by 2018-04-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $350,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 18 030

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the name of this NIH funding opportunity?

The funding opportunity is titled "Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required)."

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is RFA-AG-18-030.

What CFDA number is associated with this opportunity?

The opportunity lists CFDA 93.866.

Who is the sponsoring agency?

The sponsoring agency is the National Institutes of Health (NIH).

What is the main goal of this grant?

The main goal is to move promising dementia care and caregiver support approaches closer to real-world use by building the practical foundation needed for pragmatic trials and broader implementation in everyday community and clinical settings for people living with Alzheimer's disease and related dementias (ADRD) and their caregivers.

Is the focus on testing under ideal conditions or real-world conditions?

The opportunity emphasizes real-world conditions. It is not focused solely on testing an intervention under ideal, tightly controlled circumstances, but on preparing interventions to work in everyday community and clinical settings.

What types of research does this FOA support?

This FOA supports early-stage behavioral intervention development clinical trials aligned with Stage I, II, and III of the NIH Stage Model. Projects are expected to develop, refine, and strengthen interventions before large-scale effectiveness trials.

Does this FOA allow adapting or modifying existing interventions?

Yes. Projects can focus on adapting or modifying existing dementia care or caregiver interventions to fit real-world constraints such as staffing, time, setting, cultural context, and available resources.

What populations should the intervention focus on?

The opportunity is aimed at interventions for people living with Alzheimer's disease and related dementias (ADRD) and for family members and other caregivers who support them.

Why does the FOA emphasize understanding mechanisms or principles?

The FOA encourages researchers to examine underlying principles or mechanisms that make an intervention work, rather than treating the program as a "black box."

What does "implementation readiness" mean in this FOA?

Implementation readiness refers to preparing an intervention so it can be delivered consistently, taught to real-world providers, and sustained in routine settings where people with ADRD and their caregivers already receive support.

What is meant by "fidelity" in this opportunity?

Fidelity refers to ensuring the intervention can be delivered consistently and correctly in real-world environments outside tightly controlled research settings. The FOA encourages developing and testing methods that support real-world fidelity.

Does the FOA require training components?

Yes. The FOA calls for development of training procedures for the people who will deliver the intervention in the community or clinical setting.

Who might deliver the intervention in funded projects?

Examples mentioned include care managers, social workers, nurses, community health workers, aging services staff, and other front-line personnel depending on the setting.

What grant mechanism is used for awards under this opportunity?

The award uses the NIH R01 mechanism.

Is a clinical trial required?

Yes. The FOA explicitly requires a clinical trial.

What does "clinical trial required" imply for the study design?

It signals that funded projects must include prospective assignment to an intervention and evaluate health- or behavior-related outcomes consistent with NIH's clinical trial definition.

What is the listed award ceiling?

The listed award ceiling is $350,000.

When was this FOA created?

The FOA was created on February 5, 2018.

What was the original closing date for this funding opportunity?

The original closing date was April 10, 2018.

What types of organizations are eligible to apply?

Eligibility is broad and includes: state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses.

Are tribal entities and tribally affiliated organizations eligible?

Yes. The FOA includes federally recognized Native American tribal governments and other Native American tribal organizations, and also highlights Tribally Controlled Colleges and Universities (TCCUs).

Are community-based and faith-based organizations relevant to this FOA?

Yes. The FOA explicitly highlights faith-based or community-based organizations as additional eligible applicants and partnership-relevant institutions.

Are minority-serving institutions highlighted?

Yes. The FOA highlights Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).

Can federal agencies apply?

Yes. The FOA highlights eligible federal agencies among the additional eligible applicants and partnership-relevant institutions.

Are U.S. territories or possessions included in eligibility?

Yes. The FOA highlights U.S. territories or possessions.

Are foreign (non-U.S.) organizations eligible to apply?

Yes. The FOA notes that non-U.S. entities (foreign organizations) are included.

What is the overall intent of NIH with this opportunity?

The intent is to accelerate the pathway from promising dementia care and caregiver support ideas to interventions that can realistically be delivered at scale by funding early-stage clinical trials centered on adaptation, mechanism-focused refinement, fidelity strategies, and practical training approaches.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)

Previous opportunity: NIDA Academic Research Enhancement Award (R15, Clinical Trials Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 18 030

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 18 030) also looked into and applied for these:

Funding Opportunity
NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) Apply for PA 18 631

Funding Number: PA 18 631
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 19 130

Funding Number: RFA MH 19 130
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 633

Funding Number: PAR 18 633
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Academic Research Enhancement Award for Mechanistic and Minimal Risk Human Subjects' Research (R15 Clinical Trial Optional) Apply for PA 18 635

Funding Number: PA 18 635
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) Apply for PAR 18 632

Funding Number: PAR 18 632
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Apply for PAR 18 630

Funding Number: PAR 18 630
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) Apply for PAR 18 628

Funding Number: PAR 18 628
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM1 Clinical Trial Not Allowed) Apply for RFA AI 18 001

Funding Number: RFA AI 18 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (U01 Clinical Trial Not Allowed) Apply for RFA NS 18 015

Funding Number: RFA NS 18 015
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional) Apply for PA 18 642

Funding Number: PA 18 642
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional) Apply for PAR 18 643

Funding Number: PAR 18 643
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
NIAMS Musculoskeletal Biology and Medicine Resource-based Centers (P30 Clinical Trial Not Allowed) Apply for RFA AR 19 002

Funding Number: RFA AR 19 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NIAMS Skin Biology and Diseases Resource-based Centers (P30) Apply for RFA AR 19 001

Funding Number: RFA AR 19 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed) Apply for RFA NS 18 024

Funding Number: RFA NS 18 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp Clinical Trial Optional) Apply for PA 18 647

Funding Number: PA 18 647
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R34 Clinical Trial Optional) Apply for PA 18 653

Funding Number: PA 18 653
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 18 656

Funding Number: PAR 18 656
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pathway and Target Identification for Alzhiemers Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed) Apply for PAR 18 661

Funding Number: PAR 18 661
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 - Clinical Trial Required) Apply for PAR 18 663

Funding Number: PAR 18 663
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 18 662

Funding Number: PAR 18 662
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 18 030", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: